GlyphAllo™ (SPT-300)
Neuropsychiatric disorders
Phase 1b/2aActive
Key Facts
About PureTech Health
PureTech Health is a Boston-based biotech studio that creates and funds separate companies around innovative scientific discoveries, de-risking development and capturing value through equity and royalties. Its model has proven exceptionally successful, boasting a 6x higher clinical success rate than the industry average and delivering three FDA-approved therapies. The company's strategy leverages a deep network of academic collaborators and seasoned leadership to build a diversified portfolio across immunology, neurology, and gastroenterology.
View full company profileOther Neuropsychiatric disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| EVM301 Series | Enveric Biosciences | Discovery |
| Undisclosed Program 2 | Transneural Therapeutics | Pre-clinical |
| Undisclosed Program 3 | Transneural Therapeutics | Pre-clinical |
| ORX489 | Centessa Pharmaceuticals | Preclinical |